NCT05242107View on ClinicalTrials.gov

Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

January 1, 2022

Study Completion Date

January 10, 2022

Conditions
Lipid ProfileNeonatesIntrauterine Growth Restriction
Interventions
DIETARY_SUPPLEMENT

Omega-3 supplement group

35 Neonates were given Omega 3 in a dose of 40mg/kg/day (8), after establishment of full-feeding and for 2 weeks duration. Omega-300 (Montana pharmaceutical industry) capsule was used which contains 1000mg Omega 3 fatty acids.

OTHER

Full feeding without receiving any supplementation group

35 full term Growth Restriction( IUGR) neonates who were followed up to full feeding without receiving any supplementation.

Trial Locations (1)

Unknown

Tanta university, Tanta

All Listed Sponsors
lead

Tanta University

OTHER